St-Hubert, Canada

Masad Jose Damha

USPTO Granted Patents = 14 


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • St. Hubert, CA (2009 - 2018)
  • St-Hubert, CA (2014 - 2021)
  • Montreal, CA (2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Masad Jose Damha: Innovator in CRISPR Technology

Introduction

Masad Jose Damha is a prominent inventor based in St-Hubert, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of CRISPR technology. With a total of 14 patents to his name, Damha's work has had a profound impact on genetic engineering and molecular biology.

Latest Patents

One of his latest patents is titled "Tuning CRISPR/Cas9 activity with chemically modified nucleotide substitutions." This patent provides CRISPR/Cas9 ribonucleoprotein compositions that include chemically modified CRISPR RNA (crRNA) guide and trans-acting CRISPR RNA (tracrRNA) components. The methods of using these compositions are also detailed in the patent. Another notable patent is "Ionic tags for synthesis of oligoribonucleotides." This invention relates to the chemical synthesis of oligonucleotides, particularly oligoribonucleotides, and includes processes for making these compounds and their applications in synthesis methods.

Career Highlights

Throughout his career, Masad Jose Damha has worked at prestigious institutions such as the Royal Institution for the Advancement of Learning/McGill University and McGill University. His research has focused on advancing the understanding and application of CRISPR technology, making him a key figure in the field.

Collaborations

Damha has collaborated with notable colleagues, including Glen Deleavey and Tak-Hang Chan. These partnerships have contributed to the success of his research and the development of innovative solutions in biotechnology.

Conclusion

Masad Jose Damha's contributions to CRISPR technology and molecular biology are noteworthy. His patents and collaborations reflect his commitment to advancing scientific knowledge and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…